As of May 29, 2025, Avacta Group PLC (AVCT.L) reports a Net Margin of -107.31%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Avacta Group PLC's Net Margin
Over recent years, Avacta Group PLC's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2023-12-31 | -107.31% |
| 2022-12-31 | -379.49% |
| 2021-12-31 | -894.80% |
| 2020-12-31 | -881.11% |
| 2019-12-31 | -283.34% |
This slight downward trend highlights how Avacta Group PLC manages its overall profitability and cost control over time.
Comparing Avacta Group PLC's Net Margin to Peers
To better understand Avacta Group PLC's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Avacta Group PLC (AVCT.L) | -107.31% |
| Nanobiotix SA (NANO.PA) | 586.89% |
| Bioventix PLC (BVXP.L) | 59.51% |
| Basilea Pharmaceutica AG Allschwil (BSLN.SW) | 37.21% |
| Mabion SA (MAB.WA) | 27.21% |
| Abcam PLC (ABC.L) | 3.72% |
Compared to its competitors, Avacta Group PLC's Net Margin is about average compared to peers, reflecting typical industry profitability.